The 2026 edition of Vitafoods Europe highlights a year defined less by entirely new categories and more by strong momentum within existing ones. The show’s increasing scale makes it harder to capture all developments, reinforcing the need for curated insights based on both floor scanning and direct industry conversations.
Beauty from within emerged as a standout category, reaching a clear milestone in 2026. The space has expanded significantly in both ingredient innovation and finished product offerings, but the most notable shift is the entry of major cosmetic players into supplements. L’Oréal’s Vichy collagen launch exemplifies this convergence, mirroring the pharmaceutical industry’s expansion into nutraceuticals over a decade ago. This crossover is further reinforced by dedicated nutricosmetic tracks at trade shows and increased collaboration between cosmetic and supplement manufacturers.
Within this category, hair health stood out as a major subtrend, evolving from a niche into a highly visible segment. Numerous ingredients targeting hair growth, follicle strength, oxidative stress, and scalp health were showcased, many supported by in vitro or clinical data. Importantly, some suppliers emphasized dermatologically measured outcomes rather than self-reported results, signaling a shift toward stronger scientific positioning. Additionally, suppliers are already linking hair solutions to emerging needs such as GLP-1-related hair loss, demonstrating rapid category adaptation.
Collagen innovation remains highly active, particularly through peptides and fermentation-derived solutions. Lower-dose, clinically supported collagen peptides and vegan alternatives are gaining traction, while “tri-peptide” formats represent a key marketing and differentiation opportunity. However, regulatory uncertainty around novel peptides in Europe may influence future adoption.
The GLP-1 trend has intensified significantly since 2025, becoming one of the most visible themes at the event. Two distinct approaches are emerging: natural GLP‑1 boosters and companion supplements addressing drug side effects. While natural alternatives aim to support endogenous GLP‑1 levels, they face strong competition from highly effective pharmaceutical solutions, which are becoming more accessible and user-friendly. As a result, companion supplements appear to offer a more viable positioning, targeting issues such as dehydration, nutrient deficiencies, muscle loss, and gut discomfort. Notably, demand for such solutions is expanding into Europe, driven even by pharmaceutical companies. However, the category still lacks sufficient clinical validation, specifically in GLP‑1 users, posing a risk of overgeneralized marketing claims.
In longevity, the trend continues but remains broad and somewhat diffuse. The concept is often used as an umbrella term, with limited truly new innovation. The most promising developments center around cellular health, including NAD precursors, spermidine, and emerging molecules like 1‑MNA. While ingredient-level science is advancing, the challenge lies in translating these into clinically validated finished products with meaningful, measurable outcomes. High product costs and reliance on intermediate biomarkers raise questions about long-term market sustainability beyond the current hype cycle.
A more straightforward and fast-growing category is creatine, identified as a breakout trend. Backed by strong clinical evidence, creatine is expanding beyond sports nutrition into broader health applications, including cognitive function. Innovation is focused less on efficacy and more on improving solubility, stability, and user experience, as well as through combinations and new delivery formats.
Finally, hydration showed substantial commercial traction, with particularly strong interest from industry stakeholders. Real-world testing during the event confirmed widespread dehydration among attendees, supporting the relevance of hydration products beyond sports contexts. Innovation here is driven mainly by positioning (e.g., sugar-free everyday use) and format diversification rather than new ingredients.
Overall, Vitafoods 2026 reflects a shift toward convergence (beauty + supplements), lifecycle support (GLP‑1 companions), and format-driven differentiation—rather than entirely new category creation.
